Skip to main content

Biopeak

Category: AI in Healthcare

A full-stack longevity and healthspan optimization platform that integrates AI-driven molecular diagnostics with personalized clinical interventions to extend human healthspan. Biopeak was founded in 2024. The company is led by Rishi Pardal. Based in Bengaluru, India. Team size: 11-50. Total funding raised: $6.2M. Latest round: Seed Extension ($2.7M, Feb 2025). Key investors include ["NKSquared (Nikhil Kamath)","Claypond Capital (Ranjan Pai)","Accel (Prashanth Prakash)"].

Founded
2024
Headquarters
Bengaluru, India
Team size
11-50
Total funding
$6.2M

Value proposition

Shifts healthcare from reactive treatment to proactive, data-driven longevity management by utilizing molecular-level insights to create hyper-personalized health protocols.

Products and solutions

["AI-powered Longevity Platform (Digital)","Molecular & Epigenetic Diagnostic Testing","Personalized Healthspan Optimization Protocols","Specialized Physical Longevity Clinics","Bio-marker Tracking & Monitoring Tools"]

Unique value

India's first comprehensive longevity-focused ecosystem that bridges the gap between advanced molecular science and clinical practice, led by a former top-tier consumer goods CEO.

Target customer

Health-conscious individuals, high-net-worth individuals (HNIs), and proactive consumers seeking to optimize biological age and prevent chronic diseases.

Industries served

["Health-Tech","Longevity & Anti-aging","Personalized Medicine","Wellness & Preventive Healthcare","Artificial Intelligence"]

Technology advantage

Combines proprietary AI algorithms for synthesizing complex biological data (genomics, blood markers, and lifestyle) with a physical clinical infrastructure to provide a closed-loop health optimization experience.

How they differentiate

Full-stack approach combining AI-driven molecular diagnostics with physical longevity clinics and personalized clinical interventions.

Main competitors

["Human Edge","Vieroots","Ultrahuman"]

Key partnerships

["NKSquared (Nikhil Kamath's investment firm)","Claypond Capital (Ranjan Pai's family office)","Accel (Venture capital partner)","Connect Venture Group (Venture building and tech integration)"]

Notable customers

["High-net-worth individuals (HNIs)","Proactive health consumers","Corporate executives"]

Major milestones

["Company founded in 2024 by Rishi Pardal and Shiva Subramanian","Launched India's first specialized full-stack longevity clinic in Bengaluru","Secured $2.7M funding led by Nikhil Kamath's NKSquared in February 2025"]

Growth metrics

Launched flagship longevity clinic in Bengaluru; secured $6.2M in total capital within the first year of operations.

Market positioning

Premium healthspan optimization and longevity platform targeting high-net-worth individuals.

Geographic focus

India (Primary focus on Bengaluru and Tier-1 urban centers)

Patents and IP

No specific patents publicly disclosed as of February 2025; likely utilizing proprietary AI models and trade-secret diagnostic protocols.

About Rishi Pardal

Rishi Pardal is a seasoned corporate leader with over 30 years of experience. He most recently served as the Managing Director and CEO of United Breweries Ltd (a Heineken group company). Prior to that, he was the President of Consumer Products for the AMET region at Givaudan and spent over 20 years at Unilever in various senior leadership roles, including Vice President of Customer Development.

Official website: